Frencken Group - CGS-CIMB Research 2020-08-25: Growth To Resume In FY21F

FRENCKEN GROUP LIMITED (SGX:E28) | SGinvestors.io FRENCKEN GROUP LIMITED (SGX:E28)

Frencken Group - Growth To Resume In FY21F

  • Frencken Group held its virtual results briefing on 19 Aug 2020.
  • In our view, 2H20F performance will be better than 1H20’s but FY20F net profit will still decline by 11% y-o-y.
  • Upgrade to ADD from Reduce as the current Frencken Group share price better reflects the FY21F earnings outlook.



Frencken Group's 1H20 virtual results call on 19 Aug

  • Frencken Group (SGX:E28) held its virtual 1H20 results call on 19 Aug 2020. Key questions revolved around the outlook for 2H20F and opportunities in FY21F. Management reiterated that 2H20 performance is likely to be better than 1H20’s.
  • Given the impact from COVID-19 in 1H20, we expect Frencken Group's FY20F net profit to decline 11.1% despite the better 2H20F outlook h-o-h. Management said it will manage costs diligently.


Mechatronics outlook

  • The four key segments in the mechatronics business are:
    1. semiconductor (30% of 1H20 sales);
    2. industrial automation (20% of 1H20 sales);
    3. analytical (19% of 1H20 sales); and
    4. medical (15% of 1H20 sales).
  • Semiconductor segment’s revenue grew 73.6% y-o-y in 1H20, and given the positive semiconductor equipment spending outlook, Frencken Group expects 2H20F revenue to be stronger h-o-h.
  • Industrial automation revenue is likely to be stable h-o-h. Longer term, there could be potential demand when its key customer’s new products achieve volume production.
  • One of the key customer in the analytical segment faced greater competition in 1H20, which led to the 23.9% y-o-y revenue decline for the segment. In 2H20F, we do not expect the lost market share to be regained; hence, the modest h-o-h revenue growth guidance.
  • The medical segment should see stable revenue in 2H20F, helped by COVID-19-related medical products.


IMS outlook

  • The main segment in the IMS division is the automotive segment which accounted for 11% of 1H20 sales. This segment’s performance was negatively affected by customers’ factory shutdowns in Europe as well as the shutdown of Frencken Group’s plant in India due to COVID-19.
  • Given that customers’ plants have resumed operations, Frencken Group believes this segment will see h-o-h revenue growth in 2H20F. Frencken Group has also instituted cost reductions to mitigate the lower revenue in this segment.


Upgrade Frencken Group to ADD






William TNG CFA CGS-CIMB Research | https://www.cgs-cimb.com 2020-08-25
SGX Stock Analyst Report ADD UPGRADE REDUCE 1.060 SAME 1.060



Advertisement



MOST TALKED ABOUT STOCKS / REITS OF THE WEEK



loading.......



ANALYSTS SAY


loading.......